Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia
- 1 May 2017
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 11 (3) , 725-732.e5
Abstract
No abstract availableKeywords
Funding Information
- Fondation Leducq (13CVD03)
- Amgen
This publication has 38 references indexed in Scilit:
- Genetic predisposition to coronary heart disease and stroke using an additive genetic risk score: A population-based study in GreeceAtherosclerosis, 2012
- Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease riskBMC Medical Genetics, 2011
- Genetic Risk Score and Risk of Myocardial Infarction in HispanicsCirculation, 2011
- A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analysesThe Lancet, 2010
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorderNature, 2009
- Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence ReviewAmerican Journal of Epidemiology, 2004
- Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemiaAtherosclerosis, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- Homozygous familial hypercholesterolemia among French Canadians in Québec Province.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974